Kidneys are one of the most important organs of the body, that filter waste and toxins, and keep us healthy. With age, poor ...

Chronic kidney disease is a gradual, irreversible loss of kidney function caused by diabetes, hypertension, or ageing. It ...

Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the ...

Sudden weight fluctuations significantly impact kidney health, increasing the risk of chronic kidney disease progression and reduced function. Both ra ...

A long-term follow-up study from a consortium of six European countries, coordinated by the department of Surgery of the ...

Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of approximately 69 mL/min/1.73 m² ...

DeLorean AI is targeting Chronic Kidney Disease by using precision predictive analytics to spot renal decline years before ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...